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Abstract
The protein composition of sputum most faithfully reflects the state of the lungs. The aim of this study was to determine whether rela-
tive qualitative and quantitative differences in protein expression of sputum could be related to active pulmonary tuberculosis. Sputum
samples were collected from 65 patients with active pulmonary tuberculosis and 38 healthy controls. Comprehensive proteomic
approaches were used to profile the proteome changes of host sputum in response to Mycobacterium tuberculosis infection using two-
dimensional electrophoresis in combination with matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrome-
try. Mascot software was used to identify proteins from protein databases. Enzyme-linked immunosorbent assay was used to confirm
the proteomic results. A total of 62 differentially expressed proteins were identified, among which, 15 proteins were up-regulated and
47 proteins were down-regulated in the tuberculosis sputum compared with the controls. Bacterial protein UqhC was the most
increased protein, whereas serum albumin was the most decreased protein in the tuberculosis sputum compared with the controls.
The enzyme-linked immunosorbent assay analysis was consistent with proteomic data. Bioinformatics analysis suggested that multiple
host cell pathways were involved in the tuberculosis infection processes, including acute phase response, signal transduction, cytoskele-
ton structure, immune response and so on. In all, for the first time, our results revealed that a number of proteins were differentially
expressed during active pulmonary tuberculosis infection. These data will provide valuable clues for further investigation of tuberculosis
pathogenesis and biomarkers for detection of active pulmonary tuberculosis infection.
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Background
In developing countries, tuberculosis (TB) is still a common
disease [1]. Investigations into the molecular pathogenesis of
TB have not provided adequate answers to the basic ques-
tion concerning the mechanisms of this disorder. Newly
available proteomic procedures are promising methods for
TB research, because specific patterns of protein expression
occurring in biofluids and tissue may be of great potential
relevance to pathogenesis and biomarkers of disease [2,3].
The protein composition of sputum most faithfully reflects
the state of the lungs and sputum can be easily collected by
non-invasive means [4,5]. However, up to now, little is
known about the effect of pulmonary TB infection on spu-
tum protein composition. Considering the important role of
proteins in assessment of lung diseases, we proposed that
protein expression was altered in cell-free sputum of
patients with active pulmonary TB. Therefore, the study
attempted to reveal protein profiles in sputum associated
with active pulmonary TB, and to explore the potential bio-
logical functions of identified candidate proteins.
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Methods
Eligibility for the 65 patients who entered into the study
included typical symptoms of pulmonary TB: fibrocavitary
lung infiltrate on chest radiograph, at least one sputum speci-
men staining positive and/or sputum culture positive. Patients
were excluded from this study if they had any other coexis-
ting acute or chronic illnesses. Also, 32 healthy age and sex-
matched subjects were recruited as controls (Table 1).
The study was performed with the approval of Weifang
Medical University local ethics committee and carried out in
compliance with the Helsinki Declaration. Informed consents
were obtained from all the subjects before the commence-
ment of the study.
For sputum collection, early morning sputum was col-
lected before starting chemotherapy, as described in previ-
ous reports [6,7]. Sputum was homogenized with an equal
volume of dithiothreitol (DTT, final concentration 10 mM) at
4C and centrifuged to yield cell-free supernatant and a cell
pellet within 1 h of collection. To control for saliva contami-
nation, the cell pellet was stained with Wright stain and used
for differential cell analysis. A sputum sample was considered
adequate for further analysis if it contained fewer than 80%
squamous cells (Fig. 1). For adequate sputum, cell-free super-
natant was aliquoted and stored immediately in liquid nitro-
gen until analysis.
For protein preparation, the supernatant samples of sputum
were desalted by Desalting Columns (Pierce, Appleton, WI,
USA) and were resuspended in solubilization buffer (5 M urea,
2 M thiourea, 2% CHAPS, 65 mM DTT, 0.5% pH 3–10
ampholyte). Protein concentration was determined using
Bradford reagent (Bio-Rad, Hercules, CA, USA). The protein
samples were pooled into TB group and control group, and
adjusted to a final concentration of 1 mg/mL by mixing equal
amounts of protein from individual TB samples and controls,
respectively. The resulting two samples were further analysed.
Gel electrophoresis and image analysis were performed as
described elsewhere [8] with some modifications. Each sam-
ple, containing 150 lg protein with the final volume of
410 lL solubilization buffer, was loaded onto 24-cm immobi-
line DryStrips (pH 3–10, non-linear) on an IEF system (Bio-
Rad). For isoelectric focusing (IEF), an active rehydration at
50 V for 12 h at 20C was performed before the focusing
programme of a total of about 70 kVh as follows: 100 V for
0.5 h, 300 V for 0.5 h, 600 V for 0.5 h, 1000 V for 0.5 h,
increased gradient voltage to 3000 V for 2 h, and 9000 V for
3 h. Once IEF was completed, the strips were equilibrated in
buffer (6 M urea, 30% glycerol, 2% SDS and 0.01% Bromphe-
nol blue) with addition of 1% (w/v) DTT for 15 min and 4%
(w/v) iodoacetamide for 15 min. The IEF strips were then
run on 12% SDS-PAGE using the Protean II xi system (Bio-
Rad). The gels were stained with a Bio-Rad Silver Stain and
scanned with a Bio-Rad GS-800 scanner. Gel images were
analysed using PDQuest software 7.1 (Bio-Rad). To provide
consistency, as proposed by Plymoth et al. [9], each pooled
sample was analysed in triplicate.
TABLE 1. Characteristics of participants
Characteristics TB (n = 65) Control (n = 38)
Male/female 43/22 25/13
Age, mean (range)
years
46.11 ± 23.98 (15–60) 42.53 ± 19.16 (17–55)
Thirty-nine patients were M. tuberculosis positive for both sputum smear and
culture, and 26 were sputum smear negative but culture positive. All patients
had the clinical signs and symptoms of active pulmonary TB, comprising, 82.8%
cough, 60.7% fever, 58.2% weight loss, 40.4% haemoptysis and 38.9% night
sweats. Healthy controls were free of TB infection and any clinical symptoms of
any infectious disease.
(a) (b)
FIG. 1. Protein patterns of sputum. (a) A representative TB example is shown. (b) A representative control sample is shown. The resulting two
samples containing 150 lg protein were added to pH 3–10, non-linear DryStrips (24 cm long; Bio-Rad, Hercules, CA, USA). The p values for
these spots in three independent experiments were <0.05.
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Mass spectrometry analyses were performed as described
elsewhere [10] with some modifications. Briefly, protein
spots of interest were destained, dehydrated, and then incu-
bated with modified trypsin (10 lg/mL in 25 mM ammonium
bicarbonate). Followed by double extraction, the extracts
were dried and then solubilized with matrix solution (5 lg/
lL a-cyano-4-hydroxycinnamic acid) directly onto the matrix-
assisted laser desorption/ionization (MALDI) target. The
mass spectrometry (MS) scans were acquired in positive
reflector ion mode and the spectra were accumulated until
sufficient intensity was achieved (on average 4800 laser shots
per spot). The first ten precursor ions with the highest
intensity were selected for further MS/MS analysis.
The resulting peptide mass lists were used to search the
NCBInr database. Database searches were performed using
the mascot search engine (Matrix science, Boston, MA,
USA). The taxonomy used was human or bacteria. The fol-
lowing parameters were set up for the database search: pep-
tide mass tolerance, 0.2 Da; MS/MS mass tolerance, 0.3 Da;
enzyme, trypsin; maximum number of missed cleavages, 1;
fixed modification, carbamidomethyl; variable modifications,
methionine oxidation. Protein scores >65, confidence
score(s) of MS and MS/MS spectra >95% were regarded as
positive identifications.
Enzyme-linked immunosorbent assay (ELISA) was used to
confirm the proteomics results. Interleukin-25 (IL-25) level
was measured with an IL-25 ELISA kit according to the
instructions (BioSource, Nivelles, Belgium). Optical density at
450 nm was measured using a spectrophotometer. All sam-
ples were assayed in duplicates.
Related results were presented as the mean ± standard
deviation (SD) from three independent experiments. Mean
values were statistically compared using ANOVA tests or
Student’s t-test. Statistical significance was defined as
p < 0.05.
Results
Image analysis of two-dimensional gels
Studying sputum fluid is clinically important, and greater
knowledge concerning its components holds potential value
for measuring health and disease. To get an insight into the
protein profiles induced by TB infection, a comparative pro-
teomic analysis of cell-free sputum from TB patients and
healthy controls was performed.
Pooling of the samples facilitated the initial identification
of differentially regulated proteins in the patients with active
pulmonary tuberculosis and healthy controls. Pooling also
reduced the experimental variations in the data and mini-
mized the data files subjected to computer-intensive compar-
ative analysis. Many published research findings were from
pooled samples [8,11]. Our pretest data indicated that the
profiles for the pooled samples could generally mirror the
protein profiles of individuals. So, in our study, pooled sam-
ples were used for proteomics analysis as described in other
studies [12,13].
Representative 2D gel images are shown in Fig. 1(a,b). A
mean of 900 protein spots per gel were recognized and the
volume of all spots was evaluated. Of 185 differentially
expressed protein spots, 150 were decreased and 35 were
increased in the TB sample compared with the controls.
Compared with the controls, levels of proteins in the TB
sample were increased on average by 2.2- to 6-fold, but
decreased on average by 2.1- to 100-fold.
Protein identification and differentially expressed proteins
All differentially expressed proteins are summarized in
Table 2. The result of matrix-assisted laser desorption/
ionization-time of flight/time of flight-mass spectrometry
MALDI-TOF/TOF-MS analysis of IL-25 is shown in Fig. 2 as an
example. Out of the 62 proteins, 15 were up-regulated,
whereas 47 were down-regulated in the TB samples com-
pared with the controls. Among the 62 identified proteins, 55
are from humans and seven are from bacteria, respectively.
Confirmation of IL-25 expression by ELISA
Because proteomics results were derived from the pooled
sputum samples, to validate our proteomics results, ELISA
analysis was further performed for the detection of individual
samples from all the cases. To confirm the proteomic
results, IL-25 was selected and subjected to analysis. The
data showed that IL-25 had an increased abundance in the
TB group compared with the controls (Fig. 3). The result
was consistent with the proteomic data.
Bioinformatics analysis of identified proteins from 2DE
To further understand cellular pathways involved in response
to TB infection, the identified proteins could be clustered
into several distinct groups involved in acute phase response,
signal transduction, cytoskeleton structure, immune response
and other functions (Table 2).
Discussion
Sputum fluid contains a wide variety of proteins that are
released either locally by epithelial and inflammatory cells or
through plasma exudation. Because of the diverse origin of
sputum proteins, analysis of sputum fluid may reveal
CMI Fu et al. Proteomic analysis of sputum for tuberculosis 1243
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TABLE 2. Functional classification of proteins isolated from two-dimensional electrophoresis gels of sputum and identification
of 62 significantly changed proteins
Category Protein Mra pIa Accession no. Expression
Acute phase protein Serum albumin 69348.6 6.13 gi|23307793 Down-regulated
Acute phase protein Albumin-like 52047.8 5.69 gi|763431 Down-regulated
Acute phase protein Alloalbumin venezia 69181.4 5.99 gi|178345 Up-regulated
Acute phase protein Chain A, crystal structure of 65178.2 5.57 gi|55669910 Down-regulated
the Ga module complexed
with human serum albumin
Acute phase protein Chain A, crystal structure 66428.9 5.67 gi|3212456 Down-regulated
of human serum albumin
Acute phase protein Chain A, human serum 66409.9 5.66 gi|31615330 Down-regulated
albumin mutant R218h
complexed with thyroxine
Acute phase protein Chain A, human serum 66369.9 5.62 gi|31615331 Down-regulated
albumin mutant R218p
complexed with thyroxine
Acute phase protein PRO2675 32553.4 6.14 gi|7770217 Down-regulated
Acute phase protein PRO2044 29228.8 6.97 gi|6650826 Down-regulated
Acute phase protein PRO1708 32150.2 6.6 gi|7959791 Down-regulated
Acute phase protein PRO2619 56745.2 5.96 gi|11493459 Down-regulated
Acute phase protein Albumin preproprotein 69321.5 5.92 gi|4502027 Down-regulated
Acute phase protein Transferrin 76999.6 6.81 gi|4557871 Down-regulated
Acute phase protein Lactoferrin 78346 8.56 gi|186833 Up-regulated
Acute phase protein Amylase alpha 57758.9 6.47 gi|224980 Down-regulated
Acute phase protein Chain B, crystal structure 37624.7 5.84 gi|2781208 Down-regulated
of fibrinogen fragment D
Acute phase protein Haptoglobin Hp2 41716.9 6.23 gi|223976 Down-regulated
Acute phase protein Alpha-2-macroglobulin 70750.8 5.47 gi|177872 Down-regulated
Signal protein LIM 18295.9 9.54 gi|45504687 Down-regulated
Signal protein SH3 62220.2 7.67 gi|1843392 Down-regulated
Signal protein Nuclear receptor subfamily 2 46125.8 8.62 gi|5032173 Down-regulated
Signal protein Lymphoid-restricted membrane protein 56178.2 5.44 gi|42789729 Down-regulated
Signal protein GTP-binding RAS-like 1 22314.4 8.94 gi|21553323 Down-regulated
Signal protein Essential meiotic endonuclease 1 homolog 2 48320.9 8.78 gi|58197552 Down-regulated
Signal protein KIAA1893 protein 81050.7 8.74 gi|15620845 Up-regulated
Signal protein KIAA1949 protein 73019.2 5.46 gi|18916755 Down-regulated
Signal protein ST6 22438.7 10.06 gi|55958259 Down-regulated
Signal protein RAD50 protein 64848.9 8.7 gi|38511824 Down-regulated
Signal protein Enolase 1 47139.3 7.01 gi|4503571 Down-regulated
Cytoskeleton structure ACTG1 protein 29392.7 5.5 gi|40226101 Down-regulated
Cytoskeleton structure FELIC 67597.9 5.99 gi|15011298 Down-regulated
Cytoskeleton structure ARP2 actin-related protein 2 homolog 44732.2 6.3 gi|15778930 Up-regulated
Cytoskeleton structure Tropomyosin isoform 28402.6 4.89 gi|854189 Up-regulated
Cytoskeleton structure Beta actin 41709.7 5.29 gi|4501885 Down-regulated
Cytoskeleton structure Actin-related protein 2 isoform b 44732.2 6.3 gi|5031571 Down-regulated
Immune response IL-25 18525 8.73 gi|18034676 Up-regulated
Immune response Poly-Ig receptor 75473.7 5.38 gi|514366 Down-regulated
Immune response Anti-HBs antibody heavy chain 51243.7 8.56 gi|41059927 Down-regulated
Immune response Immunoglobulin heavy chain variable region 9572.5 6.4 gi|27650530 Up-regulated
Immune response Ig A1 Bur 73330.9 9.24 gi|229585 Up-regulated
Bacteriostatic protein Cysteine-rich protein 3 22455.8 9.2 gi|116517305 Down-regulated
Bacteriostatic protein S100A8 10827.7 6.51 gi|21614544 Down-regulated
Bacteriostatic protein Chain A, Neutrophil Gelatinase-Associated
Lipocalin
20662.6 9.1 gi|29726386 Down-regulated
Bacteriostatic protein Lysozyme precursor 16544.2 9.38 gi|307141 Down-regulated
Bacterial protein MT3876 18414.6 11.35 gi|15843389 Up-regulated
Bacterial protein 50S ribosomal protein L3 23372.3 10.27 gi|50955566 Up-regulated
Bacterial protein UqhC 34551.9 8.26 gi|28875479 Up-regulated
Bacterial protein Aspartyl/glutamyl-trna amidotransferase
subunit b
54580.8 4.84 gi|38233683 Up-regulated
Unnamed bacterial protein Hypothetical protein 43842.2 8.5 gi|10764643 Up-regulated
Unnamed bacterial protein Hypothetical protein 70651.9 8.85 gi|21739648 Up-regulated
Unnamed bacterial protein Hypothetical protein 86940.1 5.29 gi|10438291 Up-regulated
Unnamed protein Hypothetical protein 52689.8 8.83 gi|34526069 Down-regulated
Unnamed protein Hypothetical protein 17712.7 5.2 gi|16306948 Down-regulated
Unnamed protein Hypothetical protein 70651.9 8.85 gi|21739648 Down-regulated
Unnamed protein Hypothetical protein 78288 8.56 gi|467237 Down-regulated
Unnamed protein Hypothetical protein 48610.5 9.02 gi|34527430 Down-regulated
Unnamed protein Hypothetical protein 2212.2 9.79 gi|553734 Down-regulated
Unnamed protein Hypothetical protein 2212.2 9.79 gi|553734 Down-regulated
Unnamed protein Hypothetical protein 23693.6 5.17 gi|106482 Down-regulated
Unnamed protein Hypothetical protein 52536.8 7.29 gi|190570174 Down-regulated
Unnamed protein Hypothetical protein 48610.5 9.02 gi|34527430 Down-regulated
Unnamed protein Hypothetical protein 2212.2 9.79 gi|553734 Down-regulated
The pI and mass values were obtained from the MASCOT database (gi, Gene bank ID).
aCalculated value.
1244 Clinical Microbiology and Infection, Volume 18 Number 12, December 2012 CMI
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 1241–1247
important pathological mediators and may enable more accurate
characterization of many lung diseases at the molecular level.
Differential-display proteomics offers the opportunity to
understand disease mechanisms and to develop new biomar-
kers for early diagnosis. In this report, we present the first
differential proteomic analysis of sputum from patients with
active pulmonary tuberculosis and healthy controls.
In the present study, bioinformatics analysis suggested the
62 identified proteins are involved in acute phase response,
signal transduction, cytoskeleton structure, immune response
and so on. Major biological functions of the acute phase pro-
teins are to restore homeostasis and to improve survival.
Albumin, as a nutritional factor and an acute phase protein,
was significantly reduced in the serum of pulmonary TB
patients. In the present study, levels of albumin and its deriv-
atives were obviously decreased in the sputum of patients
with pulmonary TB. One of the possible causes of the low
sputum albumin was considered to be low nutritional status
of patients with active pulmonary TB. Iron (Fe) acquisition is
critical to the metabolism and growth of mycobacterium
tuberculosis (MTB), which can acquire Fe from extracellular
transferrin and lactoferrin. Transferrin was a negative acute
phase reactant and this may explain a decrease in sputum
transferrin, which was in agreement with a reduction in
serum transferrin [14]. Lactoferrin had antimicrobial activity
and was part of the innate defence, mainly at mucoses [15].
Limited data are available on the relationship between lacto-
ferrin and pulmonary TB. Our results showed that lactofer-
rin was increased in the TB sputum, which was identical to
the increase in plasma lactoferrin [16]. In the present study,
alpha-2-macroglobulin and haptoglobin Hp2 had obviously
declined in the TB sputum, which was in contrast to the
findings of Adedapo et al. [17]. The detailed mechanism is
unknown.
Eleven signal-related proteins were identified in the pres-
ent study, among which, only KIAA1893 was up-regulated.
LIM and SH3 decreased in the TB sputum, and were involved
in signal transduction and organization of the actin filaments
during various cellular processes [18]. The exact cellular
FIG. 2. The result of the matrix-assisted laser desorption/ionization-time of flight/time of flight-mass spectrometry MALDI-TOF/TOF-MS analysis
of the protein IL-25. It was identified to be human IL-25 (NCBI accession number: 18034676) by protein database search. (a) Peptide mass fin-
gerprint. (b) MS/MS profile of the peptide with a mass of 1045.56 Da; amino acids indicated as ASEDGPLNSR; confidence score 99.783%.
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FIG. 3. Confirmation of IL-25 expression by ELISA. The data
showed that IL-25 had an increased abundance in the TB group com-
pared with the control group. #The p value for IL-25 was <0.05 in
the active TB group compared with the controls.
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functions of LIM and SH3 are as yet unknown. Nuclear
receptor subfamily 2 was involved in signalling pathways and
had been shown to regulate pathways in embryonic develop-
ment, as well as in maintenance of proper cell function in
adults [19]. Lymphoid-restricted membrane protein was
expressed in a developmentally regulated fashion in both B-
and T cell-lineages, which suggested an important role for
Lrmp in the IP3-Ca2+ signal cascade [20]. GTP-binding RAS-
like 1 belonged to a distinct branch of the functionally
diverse Ras superfamily of monomeric GTPases [21].
KIAA1893 (G protein-regulated inducer of neurite out-
growth 1) was a critical subunit of N-methyl-D-aspartate
receptors, members of the glutamate receptor channel
superfamily, which were heteromeric protein complexes
with multiple subunits arranged to form a ligand-gated ion
channel [22]. Little is known about the function of
KIAA1949. ST6 could catalyze the transfer of sialic acid to
GalNAc, and showed a highly restricted pattern of expres-
sion in normal adult tissues, being largely limited to the gas-
trointestinal tract and absent in mammary glands [23].
RAD50 was involved in several critical cellular functions,
including the repair of damaged DNA [24]. Enolase-1 may
act as a cell surface plasminogen receptor during inflamma-
tory cell invasion [25]. Up to now, the relationships between
the above-mentioned 11 signal-related proteins and TB are
little known.
Six cytoskeleton-related proteins were identified in our
study, among which, only ARP2 actin-related protein 2
homolog and tropomyosin isoform were up-regulated, and
the others were down-regulated. The cytoskeleton consists
of dynamic filamentous structures. Actin proteins are
important for cell movement and maintaining the cytoskel-
eton, which is the structural framework that determines
cell shape and organizes cell contents. ACTG1 protein,
ARP2 actin-related protein 2 homolog, beta actin and
actin-related protein 2 isoform b are parts of the actin
protein family. Tropomyosin can regulate actin-myosin
interaction and actin filament function in the cytoskeleton
[26]. FELIC, a novel protein, contains a domain homolo-
gous to the cytoskeletal protein ezrin, and forms a Lyn
interaction with the GTPase Cdc42. The detailed function
of FELIC is unknown. The above-mentioned findings sug-
gested that after TB infection, levels of some cytoskeleton-
related proteins were changed.
Five immune response-related proteins were identified in
the study, of which, three proteins were increased and the
other two were decreased. Antibody-related proteins
included anti-HBs antibody heavy chain, immunoglobulin
heavy chain variable region and Ig A1 Bur. We were more
interested in both immunoglobulin heavy chain variable
region and Ig A1 Bur, because the two antibodies might be
specific ones against antigens of Mycobacterium tuberculosis. If
so, the two antibodies might be used as biomarkers for diag-
nosis of active pulmonary TB. IL-25 is a recently identified
member of the IL-17 cytokine family. Unlike the other mem-
bers of this family, IL-25 promotes T helper (Th) 2 responses
by driving the expression of IL-4, IL-5 and IL-13 [27]. TB
infection itself is characterized by relatively high levels of Th2
cytokines such as IL-4, IL-5 and IL-13, which down-regulate
Th1 responses, subsequently subvert adequate protective
immunity, and ultimately impair bactericidal function. We
found that IL-25 level was increased in the TB sputum com-
pared with the controls and this may partly explain why
tuberculosis infection is associated with Th2 response and
impaired bactericidal function.
Four bacteriostatic proteins were identified. Human cys-
teine-rich protein, found in exocrine secretions and secre-
tory granules of neutrophilic granulocytes, is believed to
play a role in innate immunity. S100A8 is crucial for resis-
tance against invasion by pathogenic bacteria [28]. Chain A,
Neutrophil Gelatinase-Associated Lipocalin acted as a
potent bacteriostatic agent because of its ability to capture
and deplete siderophores and constituted a critical compo-
nent of the innate immunity against bacterial infection [29].
Lysozyme is responsible for breaking down the polysaccha-
ride walls of many kinds of bacteria and thus it provides
some protection against infection. It was expected that
these bacteriostatic proteins would display increased
expression in the TB sputum; however, it was a big sur-
prise to note that the four bacteriostatic proteins were sig-
nificantly reduced in the TB sputum. The detailed
mechanism is unknown; however, at some point, it may be
confirmed that patients with TB infection are easily infected
by other pathogens because of these low-level bacterio-
static proteins.
In addition to the identified 11 hypothetical human pro-
teins, it is noteworthy that seven bacterial proteins were
identified, including three unnamed bacterial proteins. Among
the bacterial proteins, we were especially interested in
MT3876. MT3876 is a hypothetical protein from MTB and
function of the protein remains unknown. MT3876 may be a
biomarker of active pulmonary TB infection.
In all, for the first time, our results revealed that a num-
ber of proteins were differentially expressed during active
pulmonary tuberculosis infection. However, the relationship
between TB infection and protein expression is just begin-
ning to be explored and further investigation is needed to
provide researchers and clinicians with a better understand-
ing of tuberculosis pathogenesis and biomarkers for detec-
tion of active pulmonary tuberculosis infection.
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